You are here

Article Text

Article menu
Download PDFPDF
HSV-2 specific seroprevalence among various populations in Rome, Italy
  1. B Suligoi1,
  2. M Cusan2,
  3. P Santopadre3,
  4. G Palù4,
  5. S Catania5,
  6. G Girelli6,
  7. S Pala7,
  8. V Vullo8,
  9. The Italian Herpesmanagement Forum*
  1. 1Reparto AIDS e MST, Istituto Superiore di Sanità, Rome, Italy
  2. 2Istituto di Microbiologia, University of Padua, Padua, Italy
  3. 3Clinica Malattie Infettive, “La Sapienza” University, Rome, Italy
  4. 4Istituto di Microbiologia, University of Padua, Padua, Italy
  5. 5Clinica Malattie Infettive, “La Sapienza” University, Rome, Italy
  6. 6Dipartimento di biotecnologie cellulari ed ematologia, “La Sapienza” University, Rome, Italy
  7. 7Clinica Dermatologica, “La Sapienza” University, Rome, Italy
  8. 8Clinica Malattie Infettive, “La Sapienza” University, Rome, Italy
  1. Barbara Suligoi, National AIDS and STD Unit, Istituto Superiore di Sanità, V le Regina Elena 299, 00161 Rome, Italy suligoi{at}iss.it

https://doi.org/10.1136/sti.76.3.213

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Demographic data

    We conducted a cross sectional seroprevalence study on anonymous banked blood samples taken from adults for various reasons, between January and September 1998 at “La Sapienza” University Hospital, Rome, Italy. Blood samples were available for the following four groups of individuals:

    1. military recruits, from various Italian regions, undergoing routine medical examination for enrolment in the military service

    2. people attending an outpatient facility for either vaccination against viral hepatitis B or post-exposure prophylaxis

    3. blood donors

    4. pregnant women undergoing routine serological controls.

    Methods

    TEST USED

    All samples were tested with a commercially available kit approved by the US Food and Drug Administration: the herpes simplex virus (HSV) type 2 specific gG ELISA test manufactured by Meridian Diagnostics Inc (Cincinnati, OH, USA). The sensitivity and specificity of the test are 98% and 97%, respectively.1

    STATISTICS

    To test …

    View Full Text

    Footnotes

    • ↵* The Italian Herpes Management Forum (consisting of F Boselli, R Caputo, M Cusini, S Delia, G Gentile, P Martino, G Palù, B Suligoi, A Volpi, V Vullo) designed the study and were involved in discussion of the results.